Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR)

Historical Holders from Q1 2023 to Q3 2025

Symbol
GPCR on Nasdaq
Type / Class
Equity / Ordinary Shares, $0.0001 par value
Shares outstanding
172,779,139
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
56,638,847
Holdings value
$1,582,549,935
% of all portfolios
0.005%
Number of holders
155
Number of buys
78
Number of sells
-85
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 11.9% +20% $577,681,944 +$99,790,236 20,631,498 +20.9% Wellington Management Group LLP 31 Oct 2025
FMR LLC 11.6% $373,796,154 19,946,433 FMR LLC 30 Jun 2025
Avoro Capital Advisors LLC 9.38% $454,066,620 16,216,665 Avoro Capital Advisors LLC 30 Sep 2025
Deep Track Capital, LP 7.32% -17.8% $354,128,124 -$77,120,904 12,647,433 -17.9% Deep Track Capital, LP 30 Sep 2025
BIOTECHNOLOGY VALUE FUND L P 5.6% $171,089,168 9,611,751 BVF PARTNERS L P/IL 11 Aug 2025
Capital Research Global Investors 3.8% $168,218,991 6,492,435 Capital Research Global Investors 31 Mar 2025
JANUS HENDERSON GROUP PLC 7.7% -3.8% $124,567,128 -$3,477,040 4,448,826 -2.7% JANUS HENDERSON GROUP PLC 30 Sep 2025

Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 56,638,847 $1,582,549,935 +$86,587,271 $28 155
2025 Q2 54,653,188 $1,133,630,623 -$12,998,783 $20.74 172
2025 Q1 55,933,663 $980,564,651 -$97,541,400 $17.31 150
2024 Q4 60,660,143 $1,645,431,741 -$123,990,833 $27.12 162
2024 Q3 61,353,442 $2,685,754,151 +$108,882,886 $43.89 160
2024 Q2 59,255,636 $2,326,748,242 +$609,713,327 $39.27 164
2024 Q1 43,607,566 $1,861,796,908 +$49,174,094 $42.86 119
2023 Q4 42,586,066 $1,736,374,072 +$365,354,803 $40.76 121
2023 Q3 32,752,287 $1,641,782,565 +$750,250,715 $50.42 83
2023 Q2 17,647,287 $699,362,453 +$105,685,176 $41.57 48
2023 Q1 14,419,544 $343,038,725 +$343,038,726 $23.79 38